How should a placental chorioangioma be managed, considering tumor size and fetal impact?

Management of Placental Chorioangioma

For placental chorioangiomas ≥4-5 cm, implement intensive fetal surveillance with serial ultrasound and Doppler studies every 1-2 weeks, and proceed with in-utero intervention (fetoscopic laser photocoagulation or interstitial laser ablation) when the fetus develops signs of cardiovascular compromise—specifically elevated combined cardiac output, worsening polyhydramnios, or abnormal Doppler velocimetry—but critically, before the development of fetal hydrops, as intervention after hydrops develops is associated with fetal demise. 1, 2

Risk Stratification by Tumor Size

Small Chorioangiomas (<4-5 cm)

• These tumors occur in approximately 1% of pregnancies and are typically asymptomatic with no clinical significance 1
• Routine prenatal care without additional surveillance is appropriate 1
• Expectant management yields excellent outcomes, with a 96% live-birth rate 2

Large Chorioangiomas (≥4-5 cm)

• These represent high-risk pregnancies requiring tertiary-level multidisciplinary care 1, 3
• Associated with significant maternal complications including polyhydramnios (occurs in 67% of intervention-requiring cases), preterm labor, and postpartum hemorrhage 3, 2
• Fetal complications include high-output cardiac failure, hydrops fetalis, anemia, thrombocytopenia, and perinatal death 1, 3

Surveillance Protocol for Large Tumors

Implement the following monitoring schedule:

• Serial ultrasound every 1-2 weeks to assess tumor growth and amniotic fluid volume 1, 2
• Fetal echocardiography to calculate combined cardiac output (CCO), as elevated CCO precedes clinical decompensation 4, 2
• Middle cerebral artery (MCA) Doppler to detect fetal anemia before overt hydrops develops 4, 2
• Umbilical artery and venous Doppler velocimetry to identify placental insufficiency and cardiovascular compromise 4
• Assessment for polyhydramnios, which signals high-output cardiac state 2

The cardiovascular profile score (CVPS) provides semiquantitative assessment incorporating heart size, myocardial function, arterial and venous Doppler, and presence of hydrops 4

Intervention Thresholds and Techniques

Proceed with in-utero intervention when ANY of the following develop:

• Elevated combined cardiac output on fetal echocardiography 2
• Progressive or severe polyhydramnios requiring intervention 2
• Abnormal umbilical artery or venous Doppler waveforms 2
• MCA Doppler suggesting fetal anemia 2

Critical timing consideration: All three cases with established hydrops at the time of intervention resulted in fetal demise, whereas intervention before hydrops development improved survival 2. This represents the most important prognostic factor.

Technique Selection Based on Placental Location and Vascular Anatomy

For posterior placenta with large feeding vessels (≥3 mm):

• Two-port fetoscopic laser photocoagulation is the preferred approach 2
• One port uses bipolar forceps for vessel occlusion, the second port delivers laser photocoagulation downstream 2
• This technique improves efficiency for large-vessel tumors 2

For posterior placenta with small feeding vessels (<3 mm):

• Single-port fetoscopic laser photocoagulation is adequate 5, 2
• Diode laser coagulation of feeding vessels can achieve complete obliteration of blood supply 5

For anterior placenta (regardless of vessel size):

• Interstitial laser ablation (ILA) or radiofrequency ablation (RFA) are the accessible options 2
• These avoid the technical challenges of posterior fetoscopy through anterior placenta 2

For tumors near umbilical cord insertion:

• Exercise extreme caution with any ablative technique 2
• Consider expectant management with supportive measures if vessels cannot be safely accessed 2

Supportive Interventions

Amnioreduction should be performed for symptomatic or severe polyhydramnios to reduce preterm labor risk and maternal discomfort 2

Intrauterine transfusion (IUT) is indicated when MCA Doppler suggests fetal anemia, though one case experienced fetal demise following IUT prior to planned laser intervention 2

Delivery Planning

For expectantly managed cases or successful intervention:

• Aim for delivery at 37 weeks if stable 6
• Cesarean section is often indicated due to associated complications (preeclampsia, labor arrest, fetal distress) 6, 3
• Ensure immediate availability of neonatal intensive care, as neonates frequently require blood product transfusion for anemia and thrombocytopenia 3
• Prepare for postpartum hemorrhage with uterotonic agents readily available, as the placenta develops intermittent uterine atony 3

For cases with persistent fetal compromise despite intervention:

• Balance fetal maturity against ongoing cardiovascular stress 3
• Administer corticosteroids for fetal lung maturity if delivery anticipated before 37 weeks 3
• Emergency cesarean delivery may be required for suspicious fetal heart rate tracings 3

Critical Pitfalls to Avoid

The most significant error is delaying intervention until hydrops develops—this is uniformly fatal based on available evidence 2. Intervene when cardiovascular compromise is detected but before hydrops manifests.

Do not rely on normal anomaly scans for reassurance—the fetal structural survey may be entirely normal despite a large chorioangioma 3. The risk is hemodynamic, not structural.

Avoid underestimating postpartum hemorrhage risk—have multiple uterotonic agents prepared and consider active management of the third stage 3.

Send the placenta for histopathological confirmation in all cases 6, 3.